 | Clearside Bio up 15% premarket on FDA acceptance of Xipere NDA
seekingalpha.com - February 20 at 11:25 AM |
 | Clearside Biomedical’s Suprachoroidal Injection Platform Featured in Multiple Oral Presentations at 42nd Annual Meeting of The Macula Society
finance.yahoo.com - February 19 at 10:38 AM |
| Healthcare Companies Positioned in Major Markets
finance.yahoo.com - February 15 at 10:54 AM |
 | Clearside Biomedical Inc (CLSD) Short Interest Up 44.2% in January
www.americanbankingnews.com - February 13 at 2:08 AM |
| Clearside Biomedical Inc (CLSD) Expected to Announce Earnings of -$0.56 Per Share
www.americanbankingnews.com - February 7 at 9:38 AM |
| Clearside Biomedical Inc (CLSD) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 5 at 3:32 AM |
| Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE™ Exhibits Durability Following Second Dose
finance.yahoo.com - January 20 at 5:12 PM |
| Clearside Biomedical (CLSD) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 11 at 5:28 PM |
 | Form SC 13G Clearside Biomedical, Filed by: WHITMORE BRADFORD T - StreetInsider.com
www.streetinsider.com - January 5 at 9:23 AM |
| Clearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 9:12 AM |
| Need To Know: Clearside Biomedical, Inc. (NASDAQ:CLSD) Insiders Have Been Buying Shares
finance.yahoo.com - December 21 at 4:45 PM |
| Clearside Biomedical Submits New Drug Application for XIPERE™ for the Treatment of Macular Edema Associated with Uveitis
finance.yahoo.com - December 19 at 4:52 PM |
| Report: Exploring Fundamental Drivers Behind ForeScout Technologies, GNC, Dova Pharmaceuticals, CymaBay Therapeutics, Adesto Technologies, and Clearside Biomedical — New Horizons, Emerging Trends, and Upcoming Developments
finance.yahoo.com - November 27 at 9:49 AM |
| Clearside Biomedical Inc. (CLSD) CEO Daniel White on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 9:17 AM |
| Edited Transcript of CLSD earnings conference call or presentation 8-Nov-18 1:30pm GMT
finance.yahoo.com - November 9 at 9:35 AM |
| Clearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 8 at 9:25 AM |
| Clearside Biomedical to Participate in Stifel 2018 Healthcare Conference
finance.yahoo.com - November 7 at 4:45 PM |
 | CLSD Loses Shine, AVDL's Q3 Results Disappoint, CWBR Briefly Suspends NASH Trial
www.nasdaq.com - November 6 at 9:06 AM |
 | Clearside Biomedical Plunges 60% Following Phase 3 Study Results
www.benzinga.com - November 6 at 9:06 AM |
| Clearside Biomedical (CLSD) PT Lowered to $12 at JMP Securities
www.streetinsider.com - November 5 at 4:47 PM |
 | Why Clearside Biomedical Shares Were Halved
247wallst.com - November 5 at 4:47 PM |
| Clearside Biomedical to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018 – Conference Call to Follow
finance.yahoo.com - November 5 at 4:47 PM |
| Clearside Bio's Xipere flunks late-stage retinal vein occlusion study; shares down 27% premarket
seekingalpha.com - November 5 at 10:38 AM |
| Clearside Biomedical Announces SAPPHIRE Phase 3 Study of Combination Therapy in Retinal Vein Occlusion Did Not Meet Its Primary Endpoint
finance.yahoo.com - November 5 at 10:38 AM |
| Our Take On Clearside Biomedical
seekingalpha.com - October 29 at 4:33 PM |
| Presentation of Additional Analyses of Clearside’s PEACHTREE Clinical Trial Data Further Supports Potential of XIPERE™ in Treating Uveitic Macular Edema
finance.yahoo.com - October 29 at 4:33 PM |
| Clearside Biomedical Appoints Thomas A. Ciulla, M.D., MBA as Chief Medical Officer
finance.yahoo.com - October 25 at 9:10 AM |
| CLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018
finance.yahoo.com - October 22 at 4:42 PM |
| Clearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain
finance.yahoo.com - October 19 at 9:12 AM |
 | Detailed Research: Economic Perspectives on Clearside Biomedical, JELD-WEN Holding, LB Foster, Merrimack ...
globenewswire.com - October 16 at 4:39 PM |
| Clearside Biomedical Appoints Jeffrey Edwards to Board of Directors
finance.yahoo.com - September 26 at 4:34 PM |
 | Alpharetta biopharmaceutical company names GC & chief compliance officer
www.bizjournals.com - September 20 at 4:42 PM |
| Clearside Biomedical (CLSD) Announces Positive PEACHTREE Data to be Highlighted at EURETINA 2018
www.streetinsider.com - September 19 at 8:40 AM |
| Positive PEACHTREE Data to be Highlighted at EURETINA 2018
finance.yahoo.com - September 18 at 4:51 PM |
| What Investors Should Know About Clearside Biomedical Inc’s (NASDAQ:CLSD) Financial Strength
finance.yahoo.com - September 18 at 4:51 PM |
| Data From Clearside Biomedical’s Pivotal Phase 3 PEACHTREE Clinical Trial in Macular Edema Associated with Non-Infectious Uveitis to be Presented at the Retina Society 51st Annual Scientific Meeting
finance.yahoo.com - September 13 at 8:43 AM |
| Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery
finance.yahoo.com - September 12 at 4:43 PM |
| Clearside Biomedical Appoints Accomplished Pharmaceutical Industry Legal Executive, Leslie Zacks, as General Counsel and Chief Compliance Officer
finance.yahoo.com - September 11 at 4:43 PM |
| Clearside Biomedical: Buy Or Sell Before 2018 Catalysts
seekingalpha.com - September 11 at 9:08 AM |
| Clearside Biomedical to Participate in 2018 Janney Healthcare Conference
finance.yahoo.com - September 10 at 4:36 PM |
| Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality
finance.yahoo.com - September 6 at 4:48 PM |
| Clearside Biomedical Inc. (CLSD) CEO Daniel White on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 9:17 AM |
| Clearside Biomedical to Participate in 2018 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 9 at 9:17 AM |
| Clearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - August 8 at 9:07 AM |
| Clearside Biomedical to Report Second Quarter 2018 Financial Results on August 8, 2018 – Conference Call to Follow
finance.yahoo.com - August 1 at 10:45 AM |
| Laidlaw Starts Clearside Biomedical (CLSD) at Buy
www.streetinsider.com - July 30 at 4:45 PM |
| Late-Breaker Oral Presentation on Wednesday, July 25
globenewswire.com - July 17 at 8:32 AM |
| Clearside Biomedical to Present Data from its Pivotal Phase 3 (“PEACHTREE”) Trial in Macular Edema Associated with Uveitis at the 2018 American Society of Retina Specialists Annual Meeting
finance.yahoo.com - July 16 at 4:33 PM |
| Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs
finance.yahoo.com - July 11 at 4:52 PM |
| Clearside Biomedical: Upside Into Q4 Data And NDA Submission
seekingalpha.com - June 17 at 9:16 AM |
